Recent Company News

• 07:32 PM ET Aug 27, 2025
  

  Starpharma Holdings receives A$3.7M R&D tax incentive refund for FY25 (A$0.13, 0.00)

• 08:46 PM ET Aug 25, 2025
  

  Starpharma Holdings reports FY NPAT (A$10.0M) vs year-ago (A$8.2M) (A$0.13, 0.00)

• 12:53 AM ET Aug 14, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (48 total)

• 12:56 AM ET May 21, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (45 total)

• 09:51 PM ET May 21, 2025
  

  StreetAccount Summary - Australia unusual volume traders

• 09:52 PM ET Jul 30, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 07:52 PM ET Jul 30, 2025
  

  Starpharma Holdings reports Q4 net cash from / (used in) operating activities (A$2.0M) - Appendix 4C (A$0.10, 0.00)